Skip to main content
Year archive

CAREGEN CO.,LTD. — 2025 filings

All 30 regulatory filings released by CAREGEN CO.,LTD. (214370) in 2025, sourced directly from the official regulator.

30 Filings
2025 Period
2025 filings (30)
Filing Released Lang
[기재정정]단일판매ㆍ공급계약체결
Capital/Financing Update
2025-12-31 Korean
투자판단관련주요경영사항(임상시험결과) (CG-P5 펩타이드 기반 신약 후보물질의 제1상 임상시험 결과 수령)
Regulatory Filings Q4 2025
2025-12-30 Korean
[기재정정]투자판단관련주요경영사항(임상시험계획승인신청등결정) (CGP5 펩타이드 기반 신약 후보물질의 제1상 임상시험계획(IND) 승인)
Regulatory Filings
2025-10-24 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2025-09-23 Welsh
본점소재지변경
Regulatory Filings
2025-09-23 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2025-09-08 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2025-09-08 Korean
[기재정정]주주총회소집결의 (임시주주총회)
AGM Information
2025-08-18 Korean
반기보고서 (2025.06)
Interim / Quarterly Report H1 2025
2025-08-14 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release H1 2025
2025-08-12 Korean
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount
2025-08-12 Korean
주주총회소집결의 (임시주주총회)
AGM Information
2025-08-12 Korean
[기재정정]기업설명회(IR)개최
Report Publication Announcement
2025-07-15 Korean
기업설명회(IR)개최
Report Publication Announcement
2025-07-11 Korean
현금ㆍ현물배당결정 (중간배당)
Notice of Dividend Amount
2025-07-04 Korean
[기재정정]투자판단관련주요경영사항(임상시험계획승인신청등결정) (CGP5 펩타이드 기반 신약 후보물질의 제1상 임상시험계획(IND) 승인)
Legal Proceedings Report
2025-06-26 Korean
중간(분기)배당을위한주주명부폐쇄(기준일)결정
Notice of Dividend Amount
2025-06-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2025-05-21 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Q1 2025
2025-05-13 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Q1 2025
2025-05-13 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2025-03-25 Korean
감사보고서제출
Audit Report / Information FY 2024
2025-03-17 Korean
사업보고서 (2024.12)
Annual Report FY 2024
2025-03-17 Korean
주주총회소집결의
AGM Information
2025-03-10 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2025-03-10 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2025-03-10 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Q4 2024
2025-02-10 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount
2025-02-10 Korean
기타경영사항(자율공시) (마이오키 (MyoKi), 미국식품의약국(USFDA)으로부터 NDI(New Dietary Ingredients) 로 승인)
Regulatory Filings
2025-02-06 Korean
결산실적공시예고
Report Publication Announcement
2025-02-03 Korean